David Bomze
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, CAR-T cell therapy research, Immunotherapy and Immune Responses
Most-Cited Works
- → Glycolysis-Mediated Changes in Acetyl-CoA and Histone Acetylation Control the Early Differentiation of Embryonic Stem Cells(2015)660 cited
- → Association of Checkpoint Inhibitor–Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non–Small Cell Lung Cancer(2019)383 cited
- → Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors(2018)178 cited
- → Long-term culture and expansion of primary human hepatocytes(2015)144 cited
- → Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy(2021)141 cited
- → Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden(2019)129 cited
- → Topological Small-World Organization of the Fibroblastic Reticular Cell Network Determines Lymph Node Functionality(2016)121 cited
- → Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors(2023)115 cited
- → BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors(2019)98 cited
- → Alternative NF‐κB signaling regulates mTEC differentiation from podoplanin‐expressing precursors in the cortico‐medullary junction(2015)93 cited